Edwin O'Connor > Goodwin > New York, United States > Lawyer Profile

Goodwin
THE NEW YORK TIMES BUILDING
620 EIGHTH AVENUE
NEW YORK NY 10018
NEW YORK
United States
Edwin  O'Connor photo

Position

Partner / Co-Chair Capital Markets

Career

Edwin O’Connor, a partner in Goodwin’s Life Sciences group and co-chair of the Capital Markets practice, has a broad-based capital markets practice and represents issuers and underwriters in public and private corporate finance transactions, both in the United States and internationally. His experience encompasses initial public offerings, follow-on equity offerings, investment grade, high-yield and convertible debt offerings and offerings of preferred, hybrid and derivative securities. He has particular experience with capital markets transactions in the life sciences, tech and climate tech sectors.

Education

JD, University of Pennsylvania Law School 1998 / BA, Colgate University (magna cum laude) 1995

Lawyer Rankings

United States > Finance > Capital markets: equity offerings

Goodwin has achieved high levels of activity in recent years, including in large-cap and mid-cap equity offerings. The capital markets team is known for its expertise in biotechnology and life sciences, especially buoyant sectors from a volume of offerings perspective. Healthcare, real estate and tech are also key sectors. Even with a slowdown in IPOs in the second half of 2022, the capital markets team was able to turn its sights to PIPEs, private placements and ATM offerings. Along with its extensive issuer client base, the firm has strong links to underwriters. In New York, Edwin O’Connor is co-chair of the capital markets team and is a member of the life sciences group, while Siavosh Salimi is noted for both life sciences and tech deals. Silicon Valley partner Bradley Weber is co-chair of the group and is a key figure in tech IPOs and other equity offerings. Boston’s Joseph Theis is also rated.